Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grignani

Showing results (661-670 of 688) with videos related to

Pageof 69
Sort By:
Annals of Surgical Oncology|June 29, 2022
Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working GroupWilliam W Tseng, Carol J Swallow, Dirk C Strauss, et al.
JAMA Oncology|May 26, 2018
Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case SeriesAnna Maria Frezza, Robin L Jones, Salvatore Lo Vullo, et al.
Nature Genetics|May 6, 2020
Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetesAndrea Cortese, Yi Zhu, Adriana P Rebelo, et al.
JAMA Oncology|February 26, 2026
Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 MutationsAndrea Napolitano, Heikki Joensuu, Sara Rothschild, et al.
Nature Genetics|May 28, 2020
Author Correction: Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetesAndrea Cortese, Yi Zhu, Adriana P Rebelo, et al.
Cancer Treatment Reviews|April 11, 2024
Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma GroupElena Palassini, Giacomo Giulio Baldi, Sara Sulfaro, et al.
Critical Reviews in Oncology/Hematology|September 25, 2025
Extended molecular profiling in mesenchymal tumors: a consensus paper from the Italian Sarcoma GroupLorenzo D'Ambrosio, Marta Sbaraglia, Alessandra Merlini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2018
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2018
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial, G Ambrosini, M Balli, et al.
Pageof 69

Showing results (661-670 of 688) with videos related to

Sort By:
Pageof 69
Annals of Surgical Oncology|June 29, 2022
Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working GroupWilliam W Tseng, Carol J Swallow, Dirk C Strauss, et al.
JAMA Oncology|May 26, 2018
Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case SeriesAnna Maria Frezza, Robin L Jones, Salvatore Lo Vullo, et al.
Nature Genetics|May 6, 2020
Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetesAndrea Cortese, Yi Zhu, Adriana P Rebelo, et al.
JAMA Oncology|February 26, 2026
Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 MutationsAndrea Napolitano, Heikki Joensuu, Sara Rothschild, et al.
Nature Genetics|May 28, 2020
Author Correction: Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetesAndrea Cortese, Yi Zhu, Adriana P Rebelo, et al.
Cancer Treatment Reviews|April 11, 2024
Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma GroupElena Palassini, Giacomo Giulio Baldi, Sara Sulfaro, et al.
Critical Reviews in Oncology/Hematology|September 25, 2025
Extended molecular profiling in mesenchymal tumors: a consensus paper from the Italian Sarcoma GroupLorenzo D'Ambrosio, Marta Sbaraglia, Alessandra Merlini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2018
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2018
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial, G Ambrosini, M Balli, et al.
Pageof 69